The effectiveness of bridging from emergency to regular contraceptio

Not Applicable

Completed

• Conditions: Reproductive health; Pregnancy and Childbirth

• Registration Number: ISRCTN70616901
• Lead Sponsor: niversity of Edinburgh

Brief Summary

2019 Protocol article in https://pubmed.ncbi.nlm.nih.gov/31672711/ protocol (added 22/10/2020) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33189179/ results (added 16/11/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33949940/ (added 06/05/2021) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35149574/ process evaluation (added 16/05/2023)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-03-20
• Study Completion: 2020-06-26
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 636

Inclusion Criteria

Current inclusion criteria as of 31/01/2019:
1. Intake of oral emergency contraception (1.5 mg or 3 mg Levonorgestrel)
2. Capacity to give informed consent to participate in the trial which includes adherence to trial requirements
3. Willing to give contact details and be contacted at 4 months by phone or text or e-mail or post
4. Willing to give identifying data sufficient to allow data linkage with NHS registries
5. Female aged 16 years or over

Previous inclusion criteria:
1. Intake of oral emergency contraception (1.5 mg Levonorgestrel)
2. Willing to participate in the trial
3. Willing to give contact details and be contacted at 4 and 12 months by phone or text or e-mail or post
4. Willing to give identifying data sufficient to allow data linkage with NHS registries
5. Female 16 years or older

Exclusion Criteria

Current exclusion criteria as of 31/01/2019:
1 Contraindications to the POP (there are very few)
2 On medication that interacts adversely with POP
3. Already using a hormonal method of contraception
4. Require interpreting services
5. If pharmacist has concerns about non-consensual sex

Previous exclusion criteria:
1. Not willing to provide contact details or personal data sufficient to allow identification/linkage with NHS registries
2. Contraindications to the POP (there are very few)
3. On medication that interacts adversely with POP
4. Age under 16
5. Already using a hormonal method of contraception
6. Require interpreting services

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Current primary outcome measure as of 31/01/2019:<br>Effective contraception use (hormonal and intrauterine) determined by telephone contact (or survey) at 4 months.<br><br>Previous primary outcome measure:<br>1. Effective contraception use (hormonal and intrauterine) determined by telephone contact (or survey) at 4 months <br>2. Long acting reversible conraception (LARC) use, self reported at 4 months<br>3. Proportion of participants having undergone an abortion using record linkage from participants to national registries at 12 months